LCMS
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.
Pořadatel
Agilent Technologies
Agilent Technologies
Analytičtí vědci a kliničtí výzkumníci po celém světě spoléhají na Agilent a na to, že jim pomůže splnit i ty nejsložitější požadavky v laboratoři. Naše přístroje, software, služby a spotřební materiál řeší celou škálu potřeb ve Vaší laboratoři.
Tagy
Příprava vzorků
LinkedIn Logo

Systematic Evaluation of ChIP-seq Conditions with Automation

ZÁZNAM | Proběhlo Čt, 8.6.2023
Zde jsme tento single-pot protokol ChIP-seq zautomatizovali end-to-end pomocí Agilent Bravo.
Přejít na webinář
Agilent Technologies: Systematic Evaluation of ChIP-seq Conditions with Automation
Agilent Technologies: Systematic Evaluation of ChIP-seq Conditions with Automation

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is a well-established method for studying the genomic localization of DNA-associated proteins. ChIP-seq is widely used to study DNA-associated proteins such as histone modifications, chromatin regulators, and transcription factors. While ChIP-seq is highly useful, the overall experimental workflow involves multiple steps that increase the risk of introducing inconsistency within experiments and between groups. Recently, we developed a single-pot ChIP-seq with on-bead library preparation. This protocol enables generation of sequencing libraries from low cell numbers and also reduces the costs (~$60 per sample, including Illumina library preparation), enabling to scale up the number of conditions. (Texari et al., STARS Protocols, 2021).

Here, we automated this single-pot ChIP-seq protocol end-to-end using the Agilent Bravo. Our automated process is scalable - conducting between 8-96 ChIP-seq reactions . We benchmarked the automated protocol by performing manual ChIP-seq reactions in parallel and demonstrated a high reproducibility and nearly indistinguishable signal-to-noise ratio between manual and automated workflows. As a proof of principle, we used our automated ChIP-seq protocol to evaluate multiple parameters and identify optimal conditions, including shearing and crosslinking conditions, buffer compositions, and antibody ratios. Our automated ChIP-seq protocol will be publicly available and will include specific deck setups as well as software files and parameters. Lastly, we envision that our robust protocol can advance research by enabling core facilities to provide ChIP-seq as a service and can potentially be incorporated into compound screening and diagnostic frameworks.

Presenter: Alon Goren, PhD (Associate Professor, Department of Medicine, University of California San Diego)

Agilent Technologies
LinkedIn Logo
 

Mohlo by Vás zajímat

Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System

Postery
| 2026 | Agilent Technologies (ASMS)
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza

Increased sensitivity for low-input label-free proteomics using the Orbitrap Astral MS and μPAC Neo Plus Columns

Aplikace
| 2026 | Thermo Fisher Scientific
Instrumentace
LC/HRMS, LC/Orbitrap, LC/MS, LC/MS/MS
Výrobce
Thermo Fisher Scientific
Zaměření
Proteomika

Mind the pressure in preparative up-scaling – effects of particle size and solvent composition on back pressure

Technické články
| 2026 | KNAUER
Instrumentace
HPLC, Spotřební materiál, LC kolony
Výrobce
KNAUER
Zaměření
Ostatní

Two-Step Matrix Deposition for Improved MS Imaging Resolution

Postery
| 2026 | Shimadzu (ASMS)
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, MALDI, MS Imaging
Výrobce
Shimadzu
Zaměření
Farmaceutická analýza

Smart Monitoring & Optimization Solutions for SMB Processes: In-Line and Off-Line Tools for SMB Systems

Technické články
| 2026 | KNAUER
Instrumentace
HPLC
Výrobce
KNAUER
Zaměření
Farmaceutická analýza
Další projekty
GCMS
ICPMS
Sledujte nás
FacebookX (Twitter)LinkedInYouTube
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.